Cite

    Eiji Iwama et al.. “Trastuzumab emtansine for patients with non–small cell lung cancer positive for human epidermal growth factor receptor 2 exon-20 insertion mutations.” European journal of cancer, vol. 162, 2022, pp. 99–106. http://access.bl.uk/ark:/81055/vdc_100150527306.0x00002f